FDA to announce its decision on new Alzheimer’s drug

A scientist works in a laboratory at Biogen’s headquarters in Cambridge, Massachusetts. Photograph: David A White/AP

A scientist works in a laboratory at Biogen’s headquarters in Cambridge, Massachusetts. Photograph: David A White/AP

source https://www.theguardian.com/society/2021/jun/07/fda-announce-decision-new-alzheimers-drug-aducanumab